Carregant...
Second-Generation Antimitotics in Cancer Clinical Trials
Mitosis represents a promising target to block cancer cell proliferation. Classical antimitotics, mainly microtubule-targeting agents (MTAs), such as taxanes and vinca alkaloids, are amongst the most successful anticancer drugs. By disrupting microtubules, they activate the spindle assembly checkpoi...
Guardat en:
| Publicat a: | Pharmaceutics |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8309102/ https://ncbi.nlm.nih.gov/pubmed/34371703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13071011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|